Dr. Ngamije appointed Director of Global Malaria Control Programme

Dr. Daniel Ngamije Madandi, a former Rwandan Minister of Health, has been appointed as the Director of the World Health Organization (WHO)’s Global Malaria Control Programme. He is set to assume the role on April 8th, 2023.

Malaria is endemic in 93 countries across the world. In 2015, WHO adopted a strategy aimed at reducing global malaria incidence and mortality rates.

The strategy sets the target of reducing malaria cases by 40% by 2020, 75% by 2025, and 90% of global malaria incidence and deaths by 2030.

Speaking to IGIHE, Dr. Ngamije stated that the Global Malaria Control Programme is responsible for implementing these strategies.

He explained that this programme will coordinate partners involved in malaria control, as well as others who conduct advocacy to mobilize resources.

Partners include the Global Fund, the Presidential Malaria Initiative of the United States of America, European countries, researchers, and others.

Dr. Ngamije is a physician and public health specialist who served as Rwanda’s Minister of Health from February 2020 to November 28th, 2022, when he was replaced by Dr. Sabin Nsanzimana. Before this, he served as the Director for Malaria and Neglected Tropical Diseases in WHO’s Country Office based in Kigali.

From 2007-2017, Dr. Ngamije spent ten years coordinating the mobilization of resources and implementation of projects funded by multilateral and bilateral partners of the Ministry of Health through a single project’s implementation unit. He has also served in various leadership positions throughout the entire Rwandan Health System since 1995.

During his time as Rwanda’s Minister of Health, Dr. Ngamije led the development and successful implementation of the COVID-19 comprehensive response plan.

His appointment as the Director of the Global Malaria Control Programme is a significant step forward in the fight against malaria and recognition of the critical role that African leaders and experts play in achieving global health goals.